Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Molecular Biology · India · 2025-09-11

Processing Time
50 days
Decision Date
2025-09-11
Location
Arizona
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to characterize the molecular mechanisms by which lipids contribute to disease progression in metabolic diseases and medical emergencies. His work utilizes cell, animal, and biochemical models to uncover how lipids interact with cellular proteins, disrupt lipid homeostasis, and impair immune responses to establish new therapeutic targets.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses metabolic syndrome and diabetes, which affect over one-third of U.S. adults, and is supported by federal funding from the NIDDK and Department of Defense.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a documented history of high-impact publications, including papers ranked in the top 1%-10% of citations in his field, and significant peer-review experience.

3 Balance of Factors Met

Given the petitioner's specialized expertise in lipid-protein interactions and the urgent national need for improved therapeutic strategies for metabolic diseases, a waiver of the labor certification requirement is beneficial to the U.S.

Why This Petition Was Approved

The petition was approved due to the petitioner's advanced degree (Ph.D.), a strong publication record of 10 peer-reviewed articles and 135 citations, and his role as an expert reviewer (30+ reviews). The work was deemed of national importance because it addresses leading causes of U.S. hospitalizations and is supported by competitive federal funding from the NIDDK and the Department of Defense.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
Texas 84 days 2023-03-03
The petitioner proposes to work on elucidating the molecular mechanisms involved in XXX regulation and identifying XXX-related genes as drug targets for the treatment of metabolic disorders. This research aims to provide insight into how cellular transcription, metabolism, and physiology are dictated by XXX to develop new treatment options for obesity and diabetes.
View Case

Scientist

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Tennessee 42 days 2023-01-24
The petitioner proposes to continue investigating the underlying mechanisms of complicated metabolic diseases to discover novel therapeutic agents. This research aims to provide the physiological foundation necessary to drive innovation in the therapeutics market and improve outcomes for the large U.S. patient population suffering from obesity and related conditions.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
676 days 2025-10-22
The petitioner proposes to advance mechanistic understanding and treatment strategies for diabetes, cardiovascular disease, and oral cancer. The work focuses on uncovering biochemical drivers of metabolic disorders and identifying biomarkers to support earlier diagnosis and improved patient outcomes.
View Case

Postdoctoral Researcher

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Illinois 334 days 2025-01-16
The petitioner proposes to examine cellular lipid and protein abnormalities associated with neurological disorders to pinpoint drug targets and develop effective therapies. The work focuses on identifying biomarkers for the diagnosis of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Niemann-Pick. This research aims to improve patient outcomes and quality of life for those suffering from fatal medical conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 50 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist